Tyra Biosciences Stock Investor Sentiment
| TYRA Stock | USD 16.00 0.28 1.78% |
About 65% of all Tyra Biosciences' investors are looking to take a long position. The analysis of the overall investor sentiment regarding Tyra Biosciences suggests that some traders are interested. The current market sentiment, together with Tyra Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Tyra Biosciences stock news signals to limit their universe of possible portfolio assets.
Tyra |
Tyra Biosciences Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Tyra Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Tyra Biosciences that are available to investors today. That information is available publicly through Tyra media outlets and privately through word of mouth or via Tyra internal channels. However, regardless of the origin, that massive amount of Tyra data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Tyra Biosciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Tyra Biosciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Tyra Biosciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Tyra Biosciences alpha.
Tyra Biosciences Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Disposition of 1189 shares by Daniel Bensen of Tyra Biosciences at 20.0189 subject to Rule 16b-3 | 09/06/2024 |
2 | Disposition of tradable shares by Warner Douglas J of Tyra Biosciences subject to Rule 16b-3 | 09/09/2024 |
3 | Acquisition by Alan Fuhrman of 954 shares of Tyra Biosciences at 12.478 subject to Rule 16b-3 | 09/13/2024 |
4 | Disposition of tradable shares by Todd Harris of Tyra Biosciences at 25.0969 subject to Rule 16b-3 | 09/19/2024 |
5 | Disposition of 7109 shares by Todd Harris of Tyra Biosciences at 24.1877 subject to Rule 16b-3 | 09/20/2024 |
6 | Disposition of 1055 shares by Todd Harris of Tyra Biosciences at 24.0196 subject to Rule 16b-3 | 09/24/2024 |
7 | Disposition of 600 shares by Todd Harris of Tyra Biosciences at 24.01 subject to Rule 16b-3 | 09/25/2024 |
8 | Disposition of 500 shares by Todd Harris of Tyra Biosciences at 24.0 subject to Rule 16b-3 | 09/30/2024 |
9 | Tyra Biosciences, Inc. CEO Todd Harris Sells 500 Shares - MarketBeat | 10/02/2024 |
10 | Disposition of 10035 shares by Todd Harris of Tyra Biosciences at 24.3119 subject to Rule 16b-3 | 10/15/2024 |
11 | Disposition of 200 shares by Todd Harris of Tyra Biosciences at 26.37 subject to Rule 16b-3 | 10/17/2024 |
12 | Insider Sale President and CEO Todd Harris Sells 58,726 Shares of Tyra Biosciences Inc | 10/18/2024 |
13 | Acquisition by Ra Capital Management, L.p. of 2358457 shares of Tyra Biosciences at 0.001 subject to Rule 16b-3 | 10/22/2024 |
14 | Insider Sale President and CEO Todd Harris Sells 62,720 Shares of Tyra Biosciences Inc | 10/23/2024 |
15 | Tyra Biosciences Price Target Increased to 32.00 by Analysts at HC Wainwright | 10/28/2024 |
16 | Acquisition by Alan Fuhrman of 9500 shares of Tyra Biosciences at 15.9952 subject to Rule 16b-3 | 10/30/2024 |
17 | Disposition of 10750 shares by Kjellson Nina S of Tyra Biosciences at 16.4596 subject to Rule 16b-3 | 10/31/2024 |
18 | Disposition of tradable shares by Kjellson Nina S of Tyra Biosciences at 17.1594 subject to Rule 16b-3 | 11/01/2024 |
19 | Disposition of 116 shares by Kjellson Nina S of Tyra Biosciences at 17.006 subject to Rule 16b-3 | 11/04/2024 |
20 | Auour Investments LLC Sells 64,000 Shares of Tyra Biosciences, Inc. | 11/05/2024 |
21 | Disposition of 5635 shares by Kjellson Nina S of Tyra Biosciences at 17.1755 subject to Rule 16b-3 | 11/06/2024 |
22 | Acquisition by Ra Capital Management, L.p. of 1220681 shares of Tyra Biosciences at 16.25 subject to Rule 16b-3 | 11/08/2024 |
23 | Tyra Biosciences stock target cut, retains buy rating on clinical data | 11/11/2024 |
24 | Disposition of 566 shares by Kjellson Nina S of Tyra Biosciences at 16.8386 subject to Rule 16b-3 | 11/25/2024 |
Complementary Tools for Tyra Stock analysis
When running Tyra Biosciences' price analysis, check to measure Tyra Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tyra Biosciences is operating at the current time. Most of Tyra Biosciences' value examination focuses on studying past and present price action to predict the probability of Tyra Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tyra Biosciences' price. Additionally, you may evaluate how the addition of Tyra Biosciences to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |